This HTML5 document contains 23 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
rdfshttp://www.w3.org/2000/01/rdf-schema#
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
ncihttp://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
nci:C2784
rdf:type
owl:Class owl:DeprecatedClass
rdfs:label
p53:264-272 Peptide
rdfs:subClassOf
nci:C104171
nci:P106
Pharmacologic Substance Amino Acid, Peptide, or Protein
nci:P108
p53:264-272 Peptide
nci:P175
717111
nci:P200
Peptide_Vaccine
nci:P204
Chemical_Or_Drug_Affects_Cell_Type_Or_Tissue some 'Cytotoxic T-Lymphocyte' Chemical_Or_Drug_Has_Physiologic_Effect some 'T-Cell Activation' Chemical_Or_Drug_Has_Physiologic_Effect some Immunopotentiation Chemical_Or_Drug_Has_Mechanism_Of_Action some 'Antigen Sensitization'
nci:P207
C1518773
nci:P310
Retired_Concept
nci:P364
'Cellular Tumor Antigen p53'
nci:P366
P53_264-272_Peptide_MPS-128
nci:P90
<n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>p53:264-272 Peptide</n0:term-name><n0:term-group>PT</n0:term-group><n0:term-source>NCI</n0:term-source></n0:ComplexTerm> <n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>PR-147</n0:term-name><n0:term-group>SY</n0:term-group><n0:term-source>NCI</n0:term-source></n0:ComplexTerm> <n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>MPS-128</n0:term-name><n0:term-group>SY</n0:term-group><n0:term-source>NCI</n0:term-source></n0:ComplexTerm>
nci:P97
<n0:ComplexDefinition xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:def-definition>A synthetic peptide derived from the tumor suppressor protein p53 with potential use in cancer immunotherapy. p53:264-272 peptide consists of amino acid residues 264 through 272 of the p53 protein. Vaccination with this agent may induce a cytotoxic host immune response to tumor cells. (NCI04)</n0:def-definition><n0:def-source>NCI</n0:def-source></n0:ComplexDefinition>
nci:P98
Thu May 24 14:54:19 EDT 2012 - See 'p53_Peptide_Vaccine'
nci:code
C2784